Antinausea Protocol Reduces Hospital Length of Stay for Laparoscopic Nissen Fundoplication

J Cardiothorac Vasc Anesth. 2020 Jul;34(7):1853-1857. doi: 10.1053/j.jvca.2020.02.032. Epub 2020 Feb 27.

Abstract

Objective: The perioperative course of patients undergoing laparoscopic Nissen fundoplication (LNF) was reviewed to determine whether the use of a new treatment protocol consisting of total intravenous anesthesia (TIVA) plus triple antiemetic therapy was associated with shorter hospital length of stay (HLOS).

Design: Retrospective cohort.

Setting: Single academic center.

Participants: The study comprised 448 patients. Fifty-four patients undergoing LNF who received TIVA were compared with 394 who received standard inhalational anesthesia (non-TIVA) between January 2010 and June 2017.

Interventions: Patients who received TIVA were compared with those who received non-TIVA.

Measurements and main results: In multivariate analysis, TIVA was significantly associated with reduced HLOS (odds ratio 2.91, 95% confidence interval 1.47-5.78) and a 7.8% reduction in cost of care (p < 0.01). Female sex, length of surgery, and older age all were negatively associated with length of stay. The association between the use of TIVA and reduced HLOS and institutional cost was compared using univariate and multivariate analyses.

Conclusions: The use of TIVA in patients undergoing uncomplicated LNF shortens HLOS and is associated with reduced cost of care. This study illustrates that communication among surgeons and anesthesiologists results in improved patient care.

Keywords: Nissen; gastroesophageal, reflux; laparoscopic; total intravenous anesthesia.

MeSH terms

  • Aged
  • Female
  • Fundoplication
  • Gastroesophageal Reflux* / surgery
  • Hospitals
  • Humans
  • Laparoscopy*
  • Length of Stay
  • Retrospective Studies
  • Treatment Outcome